Literature DB >> 30856515

Growing Trends of Contralateral Prophylactic Mastectomy and Reconstruction in Young Breast Cancer.

Hongliang Chen1, Peng Zhang1, Mingdi Zhang1, Maoli Wang1, Fang Bai1, Kejin Wu2.   

Abstract

BACKGROUND: The aim of this study was to evaluate the trends of surgical treatments among young patients in T1N0-1M0 stage based on the Surveillance, Epidemiology, and End Results database.
MATERIALS AND METHODS: Patients aged less than 40 y diagnosed between 1998 and 2015 were enrolled, with tumors in T1N0-1M0 stage and not located in the central area. Differences in clinical-pathological characteristics were evaluated using chi-square tests. Multivariate logistic regression was used to measure the various factors associated with contralateral prophylactic mastectomy (CPM). Independent prognostic factors were evaluated by Cox model.
RESULTS: The total rate of breast-conserving surgery (BCS) was 51.6%, which declined from 64.5% in 1998 to 39.6% in 2015. The total rate of CPM was 22.7%, which increased from 3.7% in 1998 to 38.7% in 2014 despite a decline to 32.7% in 2015. Meanwhile, the rate of reconstruction increased in line with that of CPM, from 9.4% in 1998 to 35.0% in 2015. There was a trend of increasing use of implant-based reconstruction. Significant higher odds of CPM were found in recent year of diagnosis between 2010 and 2015 and in implant-based reconstruction. Patients undergoing CPM had similar survival outcomes compared with those undergoing BCS and unilateral mastectomy, whereas those undergoing BCS had better survival outcomes compared with those undergoing unilateral mastectomy.
CONCLUSIONS: A trend of growing preference for CPM and reconstruction was observed among young patients in early stage in recent years without survival benefits. Efforts should be made to promote efficient communication and evidence-based decision-making.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast conserving surgery; Contralateral prophylactic mastectomy; Reconstruction; Young breast cancer

Mesh:

Year:  2019        PMID: 30856515     DOI: 10.1016/j.jss.2019.02.002

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  5 in total

1.  Contralateral Risk-Reducing Mastectomy in Breast Cancer Patients Who Undergo Multigene Panel Testing.

Authors:  Brittany L Murphy; Min Yi; Banu K Arun; Angelica M Gutierrez Barrera; Isabelle Bedrosian
Journal:  Ann Surg Oncol       Date:  2020-07-27       Impact factor: 5.344

2.  Association Between Genetic Testing for Hereditary Breast Cancer and Contralateral Prophylactic Mastectomy Among Multiethnic Women Diagnosed With Early-Stage Breast Cancer.

Authors:  Vicky Ro; Julia E McGuinness; Boya Guo; Meghna S Trivedi; Tarsha Jones; Wendy K Chung; Roshni Rao; Elana Levinson; Carrie Koval; Donna Russo; Ilana Chilton; Rita Kukafka; Katherine D Crew
Journal:  JCO Oncol Pract       Date:  2021-10-27

Review 3.  Implant-Based Breast Reconstruction after Mastectomy, from the Subpectoral to the Prepectoral Approach: An Evidence-Based Change of Mind?

Authors:  Andrea Weinzierl; Daniel Schmauss; Davide Brucato; Yves Harder
Journal:  J Clin Med       Date:  2022-05-30       Impact factor: 4.964

4.  Clinical features, prognosis, and influencing factors of contralateral prophylactic mastectomy in 58 patients with breast cancer.

Authors:  Yiqiong Zheng; Jie Li; Chenyan Hong; Huan Wu; Wuri Lige; Aiying Qi; Jin Guo; Jiandong Wang; Li Zhu; Xiru Li; Yanjun Zhang
Journal:  Ann Transl Med       Date:  2020-12

5.  Latissimus dorsi myocutaneous flap repair is effective after neoadjuvant chemotherapy for locally advanced breast cancer.

Authors:  Lu Li; Yue Yang; Wang Li; Xian Zhao; Jia He; Shuo Mei; Xuejun Guo; Xibin Zhang; Jianghua Ran
Journal:  World J Surg Oncol       Date:  2022-04-27       Impact factor: 3.253

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.